SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

Agile Therapeutics On June 26 Established A Wholesale Acquisition Cost Of $159.75 For A Treatment Cycle Of Its Twirla Transdermal System; Each Twirla Treatment Cycle Is Packaged In A Carton Containing 3 Individually Pouched Transdermal Systems

On June 26, 2020, Agile Therapeutics, Inc. established a wholesale acquisition cost of $159.75 for a treatment cycle of its TWIRLA® (levonorgestrel and ethinyl estradiol) transdermal system.  Each TWIRLA

Benzinga · -

On June 26, 2020, Agile Therapeutics, Inc. established a wholesale acquisition cost of $159.75 for a treatment cycle of its TWIRLA® (levonorgestrel and ethinyl estradiol) transdermal system.  Each TWIRLA treatment cycle is packaged in a carton containing three (3) individually pouched transdermal systems.  TWIRLA is used in a 4-week (28 day) cycle. Patients apply 1 patch every week for 3 consecutive weeks, and each patch is worn for 7 days before being replaced by the next patch. No patch is worn during the fourth week.